These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30547299)

  • 21. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.
    Kumar P; Tripathi SK; Chen CP; Wickstrom E; Thakur ML
    Mol Imaging Biol; 2019 Feb; 21(1):130-139. PubMed ID: 29802552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
    Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
    Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
    Wild D; Antwi K; Fani M; Christ ER
    J Nucl Med; 2021 Jul; 62(Suppl 2):44S-50S. PubMed ID: 34230073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
    Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
    J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
    Zhang M; Jacobson O; Kiesewetter DO; Ma Y; Wang Z; Lang L; Tang L; Kang F; Deng H; Yang W; Niu G; Wang J; Chen X
    Bioconjug Chem; 2019 Jun; 30(6):1745-1753. PubMed ID: 31181890
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Wardak M
    J Nucl Cardiol; 2020 Dec; 27(6):2398-2401. PubMed ID: 30805772
    [No Abstract]   [Full Text] [Related]  

  • 27. [
    Bentsen S; Jensen JK; Christensen E; Petersen LR; Grandjean CE; Follin B; Madsen JS; Christensen C; Clemmensen A; Binderup T; Hasbak P; Ripa RS; Kjaer A
    J Nucl Cardiol; 2023 Oct; 30(5):2073-2084. PubMed ID: 37127725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
    Brom M; Oyen WJ; Joosten L; Gotthardt M; Boerman OC
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1345-55. PubMed ID: 20111963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
    J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural History of Myocardial α
    Dietz M; Kamani CH; Bousige C; Dunet V; Delage J; Rubimbura V; Nicod Lalonde M; Treglia G; Schaefer N; Nammas W; Saraste A; Knuuti J; Mewton N; Prior JO
    J Nucl Med; 2024 Jul; 65(7):1107-1112. PubMed ID: 38724280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of Myocardial α
    Nammas W; Paunonen C; Teuho J; Siekkinen R; Luoto P; Käkelä M; Hietanen A; Viljanen T; Dietz M; Prior JO; Li XG; Roivainen A; Knuuti J; Saraste A
    J Nucl Med; 2024 Jan; 65(1):132-138. PubMed ID: 37973184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granzyme B PET imaging inflammation and remodeling in myocardial infarction.
    Xu H; Wei Z; Chen B; Wang J; Weng H; Li J; Yang X; Zhao S
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):991-1001. PubMed ID: 37991527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward realization of 'mix-and-use' approach in ⁶⁸Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of ⁶⁸Ga-labeled NODAGA-coupled RGD peptide derivative.
    Chakraborty S; Chakravarty R; Vatsa R; Bhusari P; Sarma HD; Shukla J; Mittal BR; Dash A
    Nucl Med Biol; 2016 Jan; 43(1):116-123. PubMed ID: 26527030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
    Beaino W; Anderson CJ
    J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer.
    Sun Y; Ma X; Zhang Z; Sun Z; Loft M; Ding B; Liu C; Xu L; Yang M; Jiang Y; Liu J; Xiao Y; Cheng Z; Hong X
    Bioconjug Chem; 2016 Aug; 27(8):1857-64. PubMed ID: 27399868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
    Du J; Zhang L; Wang Z; Yano N; Zhao YT; Wei L; Dubielecka-Szczerba P; Liu PY; Zhuang S; Qin G; Zhao TC
    Am J Physiol Cell Physiol; 2016 Feb; 310(4):C270-83. PubMed ID: 26739490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Chemotherapy-Induced Organ Damage with Ga-68 Labeled Duramycin.
    Rix A; Drude NI; Mrugalla A; Baskaya F; Pak KY; Gray B; Kaiser HJ; Tolba RH; Fiegle E; Lederle W; Mottaghy FM; Kiessling F
    Mol Imaging Biol; 2020 Jun; 22(3):623-633. PubMed ID: 31396770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular imaging of fibroblast activation protein after myocardial infarction using the novel radiotracer [
    Langer LBN; Hess A; Korkmaz Z; Tillmanns J; Reffert LM; Bankstahl JP; Bengel FM; Thackeray JT; Ross TL
    Theranostics; 2021; 11(16):7755-7766. PubMed ID: 34335962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.